The blue-chip FTSE 100 was down 0.5 per cent following its strongest two-day percentage gain in two weeks on Wednesday. — Reuters pic
The blue-chip FTSE 100 was down 0.5 per cent following its strongest two-day percentage gain in two weeks on Wednesday. AstraZeneca weighed the most, down 2.2 per cent. The European Commission is in advanced deal talks with Johnson & Johnson on its Covid-19 vaccine under development, sources told Reuters.
The mid-cap FTSE 250 fell 0.4 per cent, with real estate , consumer stocks and mining and metal stocks leading declines.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
European stocks ease as BoE to unveil more stimulus | Malay MailLONDON, June 18 — European stock markets eased today after recent gains, with the Bank of England set to unveil more massive cash stimulus for Britain’s virus-hit economy. Earlier, Asian equity indices closed mixed after a two-day rally, with traders weighing concerns about a new wave of...
Source: malaymail - 🏆 1. / 86 Read more »
European stocks ease as BoE to unveil more stimulus | Malay MailLONDON, June 18 — European stock markets eased today after recent gains, with the Bank of England set to unveil more massive cash stimulus for Britain’s virus-hit economy. Earlier, Asian equity indices closed mixed after a two-day rally, with traders weighing concerns about a new wave of...
Source: malaymail - 🏆 1. / 86 Read more »